Glenmark Pharmaceuticals receives approval from USFDA to market generic drug for muscle pain in American market

Glenmark Pharmaceuticals on Wednesday said its subsidiary has received approval from the US health regulator to market Chlorzoxazone tablets, used to treat muscle pain, in the American market

Press Trust of India May 27, 2020 12:14:41 IST
Glenmark Pharmaceuticals receives approval from USFDA to market generic drug for muscle pain in American market

New Delhi: Glenmark Pharmaceuticals on Wednesday said its subsidiary has received approval from the US health regulator to market Chlorzoxazone tablets, used to treat muscle pain, in the American market.

Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Chlorzoxazone tablets USP, in the strength of 375 mg and 750 mg, the drug maker said in a statement.

This marks company's first abbreviated new drug application (ANDA) approval out of its new North American manufacturing facility based in Monroe, North Carolina, it added.

According to IQVIATM sales data, for the 12 month period ending March 2020, the Chlorzoxazone had annual sales of around $20.9 million.

Click here to follow LIVE news and updates on stock markets

Glenmark's current portfolio now consists of 163 products authorised for distribution in the US while 45 ANDAs are pending with the USFDA, the company said.

In addition to these internal filings, the company continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio, it added.

Updated Date:

also read

US gun violence an ‘epidemic’, ‘international embarrassment’, Joe Biden says after Colorado, Georgia shootings
World

US gun violence an ‘epidemic’, ‘international embarrassment’, Joe Biden says after Colorado, Georgia shootings

Biden's six measures to combat the epidemic included a proposed rule to ‘stop proliferation of ghost guns’, as firearms built from home kits are known

India conveys concern after US Navy announces its freedom of navigation ops in Indian EEZ without consent
India

India conveys concern after US Navy announces its freedom of navigation ops in Indian EEZ without consent

In a statement, the US Navy's 7th Fleet said, 'This operation upheld the rights, freedoms, and lawful uses of the sea recognised in international law by challenging India's excessive maritime claims'

India, US kick off two-day naval exercise in eastern Indian Ocean region
India

India, US kick off two-day naval exercise in eastern Indian Ocean region

The Indian Navy deployed its warship Shivalik and long-range maritime patrol aircraft P8I in the 'PASSEX' exercise while the US Navy was represented by the USS Theodore Rosevelt carrier strike group